Cosmos Health Inc. (NASDAQ: COSM) announced completion of Phase 1 development for its Liv18 liver health supplement, with production scheduled ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE